National and Kapodistrian University of Athens
Study of the role of tumor microenvironment in adenoid cystic carcinoma
Abstract
dc:descriptionIntroduction: Adenoid cystic carcinoma (AdCC) is a rare, slow-growing salivary gland malignancy that relapses frequently. Despite the recent progress in the understanding of the pathobiology of the disease, little information exists regarding the impact of tumor anatomic subsite on gene expression, tumor immune microenvironment (TIME) composition, overall (OS) and disease-specific survival (DSS) and response to treatment. Aiming to address this knowledge gap, we developed a comprehensive pipeline that included the use of an in-house cohort of AdCC samples, RNA sequencing datasets from AdCC and normal salivary glands and a public clinical database of patients diagnosed with AdCC. Materials and methods: To investigate gene expression differences and compare the TIME between anatomic locations of AdCC, we used 87 samples, including 48 samples (27 AdCC and 21 normal salivary gland tissue samples) from 4 publicly available AdCC RNA sequencing datasets, and a validation set of 39 samples from an in-house cohort (30 AdCC and 9 normal salivary gland samples). RNA sequencing data were used for single sample gene set enrichment analysis (ssGSEA) and TIME deconvolution. Quantitative PCR (qPCR) and multiplex immunofluorescence (mIF) were performed on the in-house cohort. Wilcoxon rank-sum, nonparametric equality-of-medians tests and linear regression models were used to evaluate tumor subsite differences. To further explore the role of anatomical location on survival and response to treatment, we extracted demographic, treatment, and survival data from the Surveillance, Epidemiology, and End Results (SEER) database. The associations between tumor characteristics and aRT with OS and DSS were estimated using hazard ratios (HR) and 95% confidence intervals (CI).Results: AdCCs of different anatomic subsites (i.e. parotid, submandibular, sublingual and minor salivary glands) differed with respect to expression of several key tumorigenic pathways. The reactive oxygen species (ROS)/NRF2 pathway signature was significantly underexpressed in submandibular versus other major gland AdCCs (i.e. parotid, sublingual) versus other major gland AdCCs, while this was not the case among normal glands (i.e. submandibular vs. parotid vs. sublingual) normal glands. Additionally, the NRF2 pathway, whose expression was found to be positively associated with overall survival, was overexpressed in parotid gland AdCCs compared to minor and submandibular gland AdCCs. TIME deconvolution identified differences in CD4+ T cell populations between major and minor gland AdCC, and natural killer (NK) cells between minor, submandibular and parotid gland AdCCs. Meanwhile, normal submandibular glands were enriched in plasma cells compared to other normal gland controls. Submandibular gland AdCCs had the worst prognosis (adjusted DSS HR = 1.48; 95% CI = 0.99-2.20, compared to parotid), and this difference was more pronounced among patients with advanced-stage tumors (adjusted DSS HR = 1.93; 95% CI = 1.13-3.30). aRT was associated with increased overall survival only among stage III submandibular AdCC patients (HR = 0.64; 95% CI = 0.42-0.98) and had no benefit in any other group. Conclusions: Our data reveal key molecular differences between AdCC tumors of different anatomic subsites and identified that submandibular gland AdCC carries a worse prognosis than other gland subsites and may benefit from aRT. ROS and NRF2 pathways are underexpressed in submandibular and minor gland AdCCs compared to parotid, and NRF2 pathway expression is positively associated with survival. CD4+ T, NK cell, and plasma cell populations also vary by tumor subsite, suggesting that the submandibular AdCC tumor-intrinsic pathway differences observed may be responsible for influencing TIME composition and survival differences associated with these tumors.
Degree
thesis:*- Grantor dc:publisher
- National and Kapodistrian University of Athens
- Year dc:date
- 2024
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Tasoulas, Jason
- Τασούλας, Ιάσων
Subjects
dc:subject × 18- Αδενοειδές Κυστικό Καρκίνωμα
- Μικροπεριβάλλον όγκου
- Adenoid cystic carcinoma
- Tumor microenvironment
- Βιολογία
- Φυσικές Επιστήμες
- Βιολογία, διεπιστημονική προσέγγιση
- Βασική Ιατρική
- Ιατρική και Επιστήμες Υγείας
- Παθολογοανατομία
- Βασική ιατρική, γενικά
- Biological Sciences
- Natural Sciences
- Biology, interdisciplinary
- Basic Medicine
- Medical and Health Sciences
- Pathology
- Basic medicine, general
Rights
- Language dc:language
- eng
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/57520